Closure techniques in vaginal hysterectomy

Not yet recruiting

Conditions: Complete uterovaginal prolapse, (2) ICD-10 Condition: N811||Cystocele, (3) ICD-10 Condition: N812||Incomplete uterovaginal prolapse, (4) ICD-10 Condition: N818||Other female genital prolapse, (5) ICD-10 Condition: N816||Rectocele, (6) ICD-10 Condition: N815||Vaginal enterocele,

Registration Number: CTRI/2022/01/039299

Lead Sponsor: Department of obs gynae AIIMS Rishikesh

Brief Summary: The American Association of Gynecologic Laparoscopists (AAGL) recommends that â€œmost hysterectomies for benign disease should be performed either vaginally or laparoscopically.â€ PFDs (pelvic floor diseases) includes vaginal bulging, urinary or fecal incontinence, pelvic organ prolapse (POP), pelvic pain, pelvic pressure or a sense of heaviness, difficulties emptying the bladder, and other sensory and emptying abnormalities of the gastrointestinal tract. These complaints can cause sexual inactivity. Given the sensitive nature of prolapse with its effect on physical appearance of female genitals, particularly when the condition is advanced, it seems likely that such prolapse would render at least some women self-conscious. Major concern after POP surgery includes not only successful anatomical correction of any protrusion but also the impact of surgery on the quality of life including sexual life.

Only a few prospective comparative studies on sexual function before and after POP surgery have been conducted, and only a few studies have attempted to define the optimal method of vaginal cuff closure after vaginal hysterectomy (VH). Those that have, have done so only in terms of the effects of the closure type on vaginal length; they did not assess the effects of various techniques on sexual functioning. To address this area, we prospectively evaluated sexual function in women before and after VH with McCall Culdoplasty and compared the effects of horizontal and vertical vaginal cuff closure on sexuality.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: Female

Target Recruitment: 50

Inclusion Criteria

All the cases of benign Pelvic organ prolapse with Stage 2 or higher (measured using pelvic organ prolapse quantification system) will be enrolled in the study.

Exclusion Criteria

Malignant pelvic organ prolapse suspicious to be malignant.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint measured in the study will be total vaginal length. This will be measured preoperatively, immediate postoperatively at 4-6 weeks postoperatively	Vaginal Length [ Time Frame: up to 4-6 weeks post-operative] \| The primary endpoint measured in the study will be total vaginal length. This will be measured preoperatively, immediate postoperatively at 4-6 weeks postoperatively
Vaginal Length [ Time Frame: up to 4-6 weeks post-operative]	Vaginal Length [ Time Frame: up to 4-6 weeks post-operative] \| The primary endpoint measured in the study will be total vaginal length. This will be measured preoperatively, immediate postoperatively at 4-6 weeks postoperatively

Secondary Outcome Measures

Name	Time	Method
Intraoperative observation including:	1. Operative time

Trial Locations

Locations (1): AIIMS Rishikesh
🇮🇳
Dehradun, UTTARANCHAL, India
AIIMS Rishikesh
🇮🇳Dehradun, UTTARANCHAL, India
Dr Rajlaxmi Mundhra
Principal investigator
08057482137
rmundhra54@yahoo.com